Production (Stage)
Amicus Therapeutics, Inc.
FOLD
$6.22
-$0.04-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.58% | -12.67% | -10.90% | -2.09% | -10.30% |
| Total Receivables | 15.56% | 15.37% | 33.74% | 33.68% | 12.11% |
| Inventory | 117.93% | 98.98% | 102.57% | 58.27% | 125.00% |
| Prepaid Expenses | -27.46% | -29.52% | -32.99% | -32.54% | 45.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.45% | 4.49% | 7.60% | 6.67% | 7.89% |
|
|
|||||
| Total Current Assets | 18.45% | 4.49% | 7.60% | 6.67% | 7.89% |
| Net Property, Plant & Equipment | -8.24% | -10.90% | -11.56% | -7.74% | -7.46% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -16.69% | -16.07% | -15.44% | -14.87% | -14.34% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.72% | -26.48% | -11.60% | -8.86% | -12.47% |
| Total Assets | 9.43% | 0.92% | 2.94% | 2.66% | 3.04% |
|
|
|||||
| Total Accounts Payable | 56.91% | -14.37% | -41.78% | 137.07% | -63.11% |
| Total Accrued Expenses | 4.22% | -17.25% | -4.08% | 0.61% | 34.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.53% | 1.57% | 9.99% | 3.47% | 3.31% |
| Total Finance Division Other Current Liabilities | -- | 17.57% | -- | -82.61% | -- |
| Total Other Current Liabilities | -- | 17.57% | -- | -82.61% | -- |
| Total Current Liabilities | 7.59% | -11.32% | -6.68% | 5.55% | 2.69% |
|
|
|||||
| Total Current Liabilities | 7.59% | -11.32% | -6.68% | 5.55% | 2.69% |
| Long-Term Debt | 0.60% | 0.58% | -1.16% | -1.12% | -1.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.60% | -7.77% | -11.12% | -7.79% | -6.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.54% | -46.57% | -9.36% | -13.39% | -17.89% |
| Total Liabilities | 0.88% | -4.33% | -3.66% | -0.25% | -1.15% |
|
|
|||||
| Common Stock & APIC | 3.02% | 3.17% | 4.25% | 4.97% | 6.01% |
| Retained Earnings | -1.07% | -2.09% | -3.95% | -4.55% | -5.69% |
| Treasury Stock & Other | 89.65% | -2.75% | 473.93% | 109.52% | 200.81% |
| Total Common Equity | 48.10% | 21.15% | 34.22% | 18.77% | 27.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.10% | 21.15% | 34.22% | 18.77% | 27.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.10% | 21.15% | 34.22% | 18.77% | 27.42% |
|
|
|||||